Sign In
Buy NMRA
$1.74
-0.0100 (-0.571%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit First Filed by The Firm
02:45pm, Sunday, 09'th Feb 2025
NEW YORK , Feb. 9, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the common stock of Neumora Therapeu
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
Lost Money on Neumora Therapeutics, Inc.(NMRA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
07:13am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc.(NMRA)
02:03am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NMRA
12:01am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / February 8, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the common stock of
Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA
06:01pm, Saturday, 08'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 8, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal se
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Neumora business and prospects, resulting in its stock trading at inflated prices.
Investors who lost money on Neumora Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - NMRA
03:45pm, Friday, 07'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA
NMRA INVESTOR ALERT: Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
03:24pm, Friday, 07'th Feb 2025
SAN DIEGO , Feb. 7, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora
